tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RYTM Stock Latest News

Promising Outlook for Rhythm Pharmaceuticals: Buy Rating Backed by Positive Phase 3 Results and Market Expansion Plans
RatingsPromising Outlook for Rhythm Pharmaceuticals: Buy Rating Backed by Positive Phase 3 Results and Market Expansion Plans
11d ago
RYTM
Rhythm Pharmaceuticals Stock (RYTM) Surges 18% Following Positive Clinical Trial Results
PremiumMarket News
Rhythm Pharmaceuticals Stock (RYTM) Surges 18% Following Positive Clinical Trial Results
19d ago
RYTM
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
22d ago
ADTX
CRMD
Buy Rating Affirmed for Rhythm Pharmaceuticals: Promising Phase 3 Results for Setmelanotide in Obesity Treatment
PremiumRatings
Buy Rating Affirmed for Rhythm Pharmaceuticals: Promising Phase 3 Results for Setmelanotide in Obesity Treatment
22d ago
RYTM
Rhythm Pharmaceuticals price target raised to $68 from $63 at BofA
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $68 from $63 at BofA
23d ago
RYTM
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
24d ago
BMY
ARTV
Rhythm Pharmaceuticals price target raised to $92 from $81 at Canaccord
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $92 from $81 at Canaccord
25d ago
RYTM
Rhythm Pharmaceuticals price target raised to $80 from $70 at H.C. Wainwright
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $80 from $70 at H.C. Wainwright
25d ago
RYTM
Positive Phase 3 Results and Market Potential Boost Rhythm Pharmaceuticals’ Price Target
PremiumRatings
Positive Phase 3 Results and Market Potential Boost Rhythm Pharmaceuticals’ Price Target
25d ago
RYTM
Rhythm Pharmaceuticals price target raised to $77 from $72 at Morgan Stanley
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $77 from $72 at Morgan Stanley
26d ago
RYTM
Promising Phase 3 Results for Setmelanotide in Hypothalamic Obesity Drive Buy Rating
PremiumRatings
Promising Phase 3 Results for Setmelanotide in Hypothalamic Obesity Drive Buy Rating
26d ago
RYTM
BofA upgrades Rhythm Pharmaceuticals to Buy on ‘likely approvable’ data
PremiumThe Fly
BofA upgrades Rhythm Pharmaceuticals to Buy on ‘likely approvable’ data
26d ago
RYTM
Rhythm Pharmaceuticals price target raised to $91 from $80 at Wells Fargo
PremiumThe FlyRhythm Pharmaceuticals price target raised to $91 from $80 at Wells Fargo
26d ago
RYTM
Rhythm Pharmaceuticals upgraded to Buy from Neutral at BofA
Premium
The Fly
Rhythm Pharmaceuticals upgraded to Buy from Neutral at BofA
26d ago
RYTM
Promising Phase 3 Results for Setmelanotide Boost Rhythm Pharmaceuticals’ Market Potential
Premium
Ratings
Promising Phase 3 Results for Setmelanotide Boost Rhythm Pharmaceuticals’ Market Potential
26d ago
RYTM
Rhythm Pharmaceuticals Announces Positive Phase 3 Trial Results
PremiumCompany Announcements
Rhythm Pharmaceuticals Announces Positive Phase 3 Trial Results
26d ago
8K
RYTM
Rhythm Pharmaceuticals says Phase 3 TRANSCEND trial meets primary endpoint
PremiumThe Fly
Rhythm Pharmaceuticals says Phase 3 TRANSCEND trial meets primary endpoint
26d ago
RYTM
Roku, Tesla among Q2 Tactical Ideas at Wells Fargo
PremiumThe Fly
Roku, Tesla among Q2 Tactical Ideas at Wells Fargo
1M ago
COF
KKR
Strategic Positioning and Promising Trials Drive Buy Rating for Rhythm Pharmaceuticals
PremiumRatings
Strategic Positioning and Promising Trials Drive Buy Rating for Rhythm Pharmaceuticals
1M ago
RYTM
Promising Potential of Rhythm Pharmaceuticals’ Setmelanotide in Treating Hypothalamic Obesity
PremiumRatingsPromising Potential of Rhythm Pharmaceuticals’ Setmelanotide in Treating Hypothalamic Obesity
1M ago
RYTM
Buy Rating for Rhythm Pharmaceuticals: Strategic Moves in Asia and Promising Setmelanotide Trials Drive Positive Outlook
Premium
Ratings
Buy Rating for Rhythm Pharmaceuticals: Strategic Moves in Asia and Promising Setmelanotide Trials Drive Positive Outlook
1M ago
RYTM
Strategic Advancements and Market Opportunities Drive Buy Rating for Rhythm Pharmaceuticals
Premium
Ratings
Strategic Advancements and Market Opportunities Drive Buy Rating for Rhythm Pharmaceuticals
1M ago
RYTM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >